WallStreetZenWallStreetZen

NASDAQ: XGN
Exagen Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their XGN stock forecasts and price targets.

Forecast return on equity

Is XGN forecast to generate an efficient return?
Company
N/A
Industry
8.15%
Market
29.43%

Forecast return on assets

Is XGN forecast to generate an efficient return on assets?
Company
N/A
Industry
3.14%

XGN revenue forecast

What is XGN's revenue in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
$54.3M+3.33%
Avg 2 year Forecast
$64.2M+22.17%
XGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XGN revenue growth forecast

How is XGN forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
3.33%
Industry
2.41%
Market
13.2%
XGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XGN vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
XGN$1.37N/AN/A
DMTK$0.64$1.38+113.82%Buy
OCX$2.50$3.90+56.00%Buy
MYNZ$0.91$3.00+231.49%Buy
TTOO$2.96N/AN/A
View Top Diagnostic & Research Stocks

Exagen Stock Forecast FAQ

What is XGN's revenue growth forecast for 2024-2025?

(NASDAQ: XGN) Exagen's forecast annual revenue growth rate of 3.33% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.41%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.2%.

Exagen's revenue in 2024 is $52,548,000.On average, 3 Wall Street analysts forecast XGN's revenue for 2024 to be $935,901,279, with the lowest XGN revenue forecast at $934,177,704, and the highest XGN revenue forecast at $937,624,854.

In 2025, XGN is forecast to generate $1,106,535,214 in revenue, with the lowest revenue forecast at $1,085,852,313 and the highest revenue forecast at $1,147,901,017.

If you're new to stock investing, here's how to buy Exagen stock.

What is XGN's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: XGN) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 3.14%.

What is XGN's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: XGN) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.